Healthcare Videos

Keeping Tabs on Hantavirus; MA Auto-Enrollment; Mel Gibson's Ivermectin Influence

The MedPod Today episode covered three distinct health‑policy stories: a hantavirus outbreak linked to a small cruise ship, a proposal by the Centers for Medicare & Medicaid Services (CMS) to automatically enroll new beneficiaries into Medicare Advantage or accountable‑care organizations (ACOs), and a new study measuring the influence of Mel Gibson’s comments on ivermectin‑benzimidazole prescriptions. Public‑health officials identified 34 U.S. individuals connected to the cruise – seven who disembarked early, nine who traveled on a flight from St. Helena, and 18 repatriated passengers – now under quarantine or active monitoring, with most housed at the University of Nebraska Medical Center. Meanwhile, CMS is weighing auto‑enrollment to steer beneficiaries toward private‑managed plans, a move critics argue could raise costs; MedPAC reported $76 billion extra spending on Medicare Advantage in 2025 compared with traditional fee‑for‑service. The ivermectin study, published in JAMA Network Open, showed prescription rates for the unproven combination doubled in 2025 versus 2024, spiking 2.5‑fold among cancer patients, predominantly white men under 65 in the South. Researchers cited a comment from a UNMC doctor preferring facility quarantine for better survival odds, and quoted health‑policy analyst Tom Campanella warning that “denying needed and appropriate services” would be detrimental. These stories underscore the challenges of rapid disease containment, the political and fiscal stakes of Medicare reform, and the tangible impact of celebrity‑driven misinformation on prescription behavior, prompting calls for stronger surveillance, transparent enrollment safeguards, and public‑education campaigns.